A study of the value of p53, HER2, and Bcl-2 in the prediction of response to doxorubicin and paclitaxel as single agents in metastatic breast cancer: a companion study to EORTC 10923. (Q40652708)
Jump to navigation
Jump to search
scientific article published on October 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A study of the value of p53, HER2, and Bcl-2 in the prediction of response to doxorubicin and paclitaxel as single agents in metastatic breast cancer: a companion study to EORTC 10923. |
scientific article published on October 2000 |
Statements
1 reference
A study of the value of p53, HER2, and Bcl-2 in the prediction of response to doxorubicin and paclitaxel as single agents in metastatic breast cancer: a companion study to EORTC 10923. (English)
1 reference
Hamilton A
1 reference
Larsimont D
1 reference
Paridaens R
1 reference
Drijkoningen M
1 reference
van de Vijver M
1 reference
Bruning P
1 reference
Hanby A
1 reference
Houston S
1 reference
Treilleux I
1 reference
Guastalla JP
1 reference
Van Vreckem A
1 reference
Sylvester R
1 reference
Piccart M
1 reference
1 October 2000
1 reference
1 reference
1
1 reference
3
1 reference
233-40; discussion 241-2
1 reference
Identifiers
1 reference
1 reference